Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Nathan Dowden

Nathan Dowden

Senior Vice President at Rubius Therapeutics

Connect with Nathan Dowden on LinkedIn
Website:

About the author:

Nathan Dowden, SVP of Corporate Development at Rubius Therapeutics, has 25 years of strategy, investment, and operational experience in the healthcare field. Prior to Rubius, Nathan was a Managing Director in the Huron Life Science strategy consulting practice. Nathan joined Huron in 2014 after helping to lead, and finally sell another life science strategy firm, The Frankel Group, after 16 years. Clients included executive, corporate development, and technology teams within global life science firms, non-profit organizations, and start-up / emerging growth companies. Nathan has written and spoken at conferences on a wide variety of topics, ranging from stem cell commercialization and orphan drug business models, to the practical application of personalized medicine.

Earlier in his career, Nathan was a senior consultant with Ernst & Young LLP where his advisory assignments included mergers & acquisition, new business creation, & operational support work. He was also worked for the Equity4Life venture capital fund (Switzerland) and has served on a variety of start-up boards. Prior to that, Nathan worked at Searle Pharmaceuticals in their Managed Care Strategy group and at CIGNA Healthcare as an analyst & programmer. Nathan holds an MBA from The University of Chicago Booth School of Business


Posts by Nathan Dowden

Organizational Evolution: Balancing Exploration & Development

Posted on April 26th, 2017 in Pharma R&D

Rubius Therapeutics had an extraordinary 2016. We were able to dramatically progress our work on the technology platform (where we expanded the number of different ways that we can express proteins) Continue reading “Organizational Evolution: Balancing Exploration & Development” »

New Developments in R&D

Posted on January 11th, 2017 in Pharma R&D

There are some exciting changes happening at Rubius right now. We moved into a new lab,  and  more importantly, we’ve hired a new vice president of R&D, Tom Wickham. Continue reading “New Developments in R&D” »